Stocks Comparison
Edwards Lifesciences vs Inogen: revenue, profit, margins and growth compared
Edwards Lifesciences brought in $6.1B of revenue in fiscal 2025, Inogen $348.7M in fiscal 2025. Revenue changed by +11.5% at Edwards Lifesciences and +3.9% at Inogen on the year before, so Edwards Lifesciences grew faster. Edwards Lifesciences kept 17.7% of its revenue as net profit, Inogen -6.5%. Free cash flow was $1.3B at Edwards Lifesciences and -$13.7M at Inogen.
Side by side, latest fiscal year
| EW | INGN | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $6.1B | $348.7M |
| Revenue growth | +11.5% | +3.9% |
| Net income | $1.1B | -$22.7M |
| Net margin | 17.7% | -6.5% |
| Free cash flow | $1.3B | -$13.7M |
| Free cash flow margin | 22.0% | -3.9% |
| Earnings per share (diluted) | $1.83 | -$0.86 |
| Cash | $2.9B | $103.7M |
| Debt | $598.3M | n/a |
| Price to earnings | 47.1 | n/a |
| Market value | $49.7B | $142.2M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #54 of 523 · Health care | #213 of 523 · Health care |
Over the years
Questions about Edwards Lifesciences and Inogen
Which is bigger by revenue, Edwards Lifesciences or Inogen?
Edwards Lifesciences is bigger by revenue: $6.1B in fiscal 2025, against $348.7M for Inogen in fiscal 2025.
Which keeps more of its revenue as profit, Edwards Lifesciences or Inogen?
Edwards Lifesciences had a net margin of 17.7% in fiscal 2025; Inogen had -6.5% in fiscal 2025.
Which grew revenue faster, Edwards Lifesciences or Inogen?
In their latest fiscal years revenue changed by +11.5% at Edwards Lifesciences and +3.9% at Inogen.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.